Precision AQ
Stephanie Kennedy, PhDSenior Vice President
Stephanie Kennedy is a senior biopharma consultant with 15+ years of experience advising on pricing, value, and market access strategy across the product lifecycle. She leads early and launch pricing, value proposition and framework development, gap assessments, provider strategy, and coding and billing initiatives. She has significant expertise in oncology, rare disease, and cell & gene therapy. Her work spans the U.S., ex-U.S., and APAC markets, with a focus on aligning clinical evidence, reimbursement requirements, and commercial execution to enable successful global launches.
Insights from Stephanie Kennedy, PhD
Commercialization & Access | White Paper
Challenges and Opportunities for Radiopharmaceutical Commercialization